4-carboxyphenylglycine has been researched along with Cerebral Ischemia in 2 studies
4-carboxyphenylglycine: RN given for (+-)-isomer; RN for cpd without isomeric designation not available 3/93; glutamate receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soria, FN | 1 |
| Pérez-Samartín, A | 1 |
| Martin, A | 1 |
| Gona, KB | 1 |
| Llop, J | 1 |
| Szczupak, B | 1 |
| Chara, JC | 1 |
| Matute, C | 1 |
| Domercq, M | 1 |
| Henrich-Noack, P | 1 |
| Reymann, KG | 1 |
2 other studies available for 4-carboxyphenylglycine and Cerebral Ischemia
| Article | Year |
|---|---|
Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage.
Topics: Amino Acid Transport System y+; Animals; Benzoates; Brain Ischemia; Cell Death; Glutamate Plasma Mem | 2014 |
(1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia.
Topics: Animals; Benzoates; Brain Ischemia; Cell Count; Cell Survival; Cycloleucine; Dose-Response Relations | 1999 |